STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFR

Anticancer Research

Volumn 24, Issue 6, 2004, Pages 3881-3886

  Hambek, Markus ^a   Baghi, Mehran ^a   Strebhard, Klaus ^a   May, Angelika ^a   Adunka, Oliver ^a   Gstöttner, Wolfgang ^a   Knecht, Rainald ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

EGFR; Head and neck squamous cell carcinoma; STAT 3

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; STAT3 PROTEIN; DNA BINDING PROTEIN; MONOCLONAL ANTIBODY; STAT3 PROTEIN, HUMAN; STAT3 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; GENE ACTIVATION; HEAD AND NECK CARCINOMA; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; DRUG ANTAGONISM; HEAD AND NECK TUMOR; HUMAN; IMMUNOLOGY; METABOLISM; NUDE MOUSE; PHOSPHORYLATION; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; DNA-BINDING PROTEINS; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 14944373626     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Prenzel N, Fischer OM, Streit S, Hart S and Ullrich A: The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr Relat Cancer 8: 11-31, 2001.
2. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J et al: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (Lond.) 309: 418-425, 1984.
3. Zhong Z, Wen Z and Darnell JE Jr: Stat-3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 246: 95-98, 1994.
4. Darnell JE Jr: STATs and gene regulation. Science 277: 1630-1635, 1997.
5. Bromberg J and Darnell JE Jr: The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19: 2468-2473, 2000.
6. Bowman T, Garcia R, Turkson J and Jove R: STATs in oncogenesis. Oncogene 19: 2474-2488, 2000.
7. Schindler C and Darnell JE Jr: Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Ann Rev Biochem 64: 621-651, 1995.
8. Ni Z, Lou W, Leman ES and Gao AC: Inhibition of constitutively activated Stat-3 signaling pathway suppresses growth of prostate cancer cells. Cancer Res 60: 1225-1228, 2000.
9. Wu YY and Bradshaw RA: Activation of the Stat-3 signaling pathway is required for differentiation by interleukin-6 in PC12-E2 cells. J Biol Chem 275: 2147-2156, 2000.
10. Bowman T, Garcia R, Turkson J and Jove R: STATs in oncogenesis. Oncogene 19: 2474-2488, 2000.
11. Shao H, Cheng HY, Cook RG and Tweardy DJ: Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor. Cancer Res 63: 3923-3930, 2003.
12. Garcia R and Jove R: Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J Biomed Sci 5: 79-85, 1998.
13. Silvennoinen O, Schindler C, Schlessinger J and Levy DE: Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation. Science (Wash. DC) 261: 1736-1739, 1993.
14. Sebti S: New drug targets and therapies for cancer. Oncog Rev 19: 6549-6692, 2000.
15. Hambek et al: Tumor necrosis factor alpha sensitizes low epidermal growth factor receptor (EGFR)-expressing carcinomas for anti-EGFR therapy. Cancer Res 61(3): 1045-9, 2001.